Patents by Inventor Fengping LV

Fengping LV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Spiro three-membered ring, spiro five-membered ring peptide deformylase inhibitor and use thereof in antibacteria and anti-tumor
    Patent number: 10738028
    Abstract: Disclosed are the anti-bacterial activity and the anti-tumor activity of a class of new spiro three-membered ring and spiro five-membered ring peptide deformylase inhibitor. The spiro three-membered ring and spiro five-membered ring peptide deformylase inhibitor of the present invention, as a class of new anti-bacterial agent, are effective against many antibiotic-resistant Gram-positive strains by inhibiting the activity of the peptide deformylase required in the synthesis of bacterial proteins, and do not affect the synthetic process of the main proteins of the human body, thus selectively killing bacteria.
    Type: Grant
    Filed: May 10, 2017
    Date of Patent: August 11, 2020
    Assignee: RUDONG RUIEN PHARMACEUTICAL TECHNOLOGY CO. LTD
    Inventors: Wenhao Hu, Fengping Lv, Yang Tang, Ziyan Li, Chen Chen, Jianhai Wei, Suzhen Dong, Yu Qian
  • SPIRO THREE-MEMBERED RING, SPIRO FIVE-MEMBERED RING PEPTIDE DEFORMYLASE INHIBITOR AND USE THEREOF IN ANTIBACTERIA AND ANTI-TUMOR
    Publication number: 20190194165
    Abstract: Disclosed are the anti-bacterial activity and the anti-tumor activity of a class of new spiro three-membered ring and spiro five-membered ring peptide deformylase inhibitor. The spiro three-membered ring and spiro five-membered ring peptide deformylase inhibitor of the present invention, as a class of new anti-bacterial agent, are effective against many antibiotic-resistant Gram-positive strains by inhibiting the activity of the peptide deformylase required in the synthesis of bacterial proteins, and do not affect the synthetic process of the main proteins of the human body, thus selectively killing bacteria.
    Type: Application
    Filed: May 10, 2017
    Publication date: June 27, 2019
    Applicant: Rudong Ruien Pharmaceutical Technology Co. Ltd
    Inventors: Wenhao HU, Fengping LV, Yang TANG, Ziyan LI, Chen CHEN, Jianhai WEI, Suzhen DONG, Yu QIAN